We are live on
!
Find out more
DC
Defender Capital Portfolio holdings
AUM
$308M
1-Year Est. Return
4.52%
This Fund
S&P 500
This Quarter
Est. Return
+13.18%
1 Year Est. Return
+4.52%
3 Year Est. Return
+83.48%
5 Year Est. Return
+78.82%
10 Year Est. Return
–
AUM
$301M
AUM Growth
+$20.6M
(+7.4%)
Cap. Flow
-$10.4M
Cap. Flow
% of AUM
-3.44%
Top 10 Holdings %
Top 10 Hldgs %
87.84%
Holding
43
New
5
Increased
15
Reduced
11
Closed
3
Top Buys
| 1 |
Fortive
FTV
|
+$6.96M |
| 2 |
Enovis
ENOV
|
+$4.25M |
| 3 |
IMDX
Insight Molecular Diagnostics
IMDX
|
+$3.63M |
| 4 |
AXON
Axon Enterprise
AXON
|
+$1.67M |
| 5 |
Intel
INTC
|
+$1.17M |
Top Sells
| 1 |
STAAR Surgical
STAA
|
+$8.51M |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$6.55M |
| 3 |
NUAN
Nuance Communications, Inc.
NUAN
|
+$6.36M |
| 4 |
Costco
COST
|
+$2.39M |
| 5 |
PTN
Palatin Technologies
PTN
|
+$2.32M |
Sector Composition
| 1 | Healthcare | 40.21% |
| 2 | Technology | 12.71% |
| 3 | Consumer Staples | 12.5% |
| 4 | Financials | 11.54% |
| 5 | Industrials | 5.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1
Danaher
DHR
$144B
| $42.3M | 14.05% |
177,703
+1,247
| +0.7% | +$276K |
|
|
2
Vanguard Short-Term Treasury ETF
VGSH
$29.3B
| $41.3M | 13.73% |
672,647
-106,524
| -14% | -$6.55M |
|
|
3
STAAR Surgical
STAA
$1.3B
| $38.6M | 12.82% |
252,984
-64,601
| -20% | -$8.51M |
|
4
Berkshire Hathaway Class B
BRK.B
$1.06T
| $34.7M | 11.54% |
125,008
-3,939
| -3% | -$1.1M |
|
|
5
Fortive
FTV
$18.8B
| $27.3M | 9.06% |
518,858
+129,166
| +33% | +$6.96M |
|
6
Monster Beverage
MNST
$94.6B
| $21.1M | 7% |
461,150
-11,588
| -2% | -$544K |
|
|
AXON
7
Axon Enterprise
AXON
$41.6B
| $17.5M | 5.81% |
98,950
+11,320
| +13% | +$1.67M |
|
|
8
Costco
COST
$415B
| $16.5M | 5.5% |
41,825
-6,320
| -13% | -$2.39M |
|
9
Lineage Cell Therapeutics
LCTX
$294M
| $14.4M | 4.77% |
5,036,720
+86,000
| +2% | +$223K |
|
|
10
Enovis
ENOV
$1.54B
| $10.7M | 3.57% |
136,123
+55,485
| +69% | +$4.25M |
|
|
IMDX
11
Insight Molecular Diagnostics
IMDX
$154M
| $7.73M | 2.57% |
67,360
+37,137
| +123% | +$3.63M |
|
12
Invesco AI and Next Gen Software ETF
IGPT
$1.2B
| $5.24M | 1.74% |
95,385
-3,750
| -4% | -$201K |
|
13
Teledyne Technologies
TDY
$29.4B
| $4.26M | 1.41% |
10,165
-400
| -4% | -$170K |
|
|
NUAN
14
DELISTED
Nuance Communications, Inc.
NUAN
| $2.88M | 0.96% |
52,815
-120,693
| -70% | -$6.36M |
|
15
Compugen
CGEN
$222M
| $2.06M | 0.69% |
244,872
+11,000
| +5% | +$89.3K |
|
16
American Well
AMWL
$217M
| $1.83M | 0.61% |
7,289
+548
| +8% | +$158K |
|
17
Kinder Morgan
KMI
$71.7B
| $1.28M | 0.42% |
70,000
+55,000
| +367% | +$981K |
|
18
Inovio Pharmaceuticals
INO
$91.3M
| $1.25M | 0.42% |
11,289
+417
| +4% | +$40.1K |
|
|
19
Intel
INTC
$485B
| $1.22M | 0.41% |
+20,000
| New | +$1.17M |
|
20
Apple
AAPL
$4.88T
| $881K | 0.29% |
6,436
| – | – |
|
21
Amazon
AMZN
$2.66T
| $853K | 0.28% |
4,960
| – | – |
|
22
Amplify BlueStar Israel Technology ETF
ITEQ
$118M
| $812K | 0.27% |
11,607
+570
| +5% | +$38.1K |
|
23
State Street SPDR Bloomberg 1-3 Month T-Bill ETF
BIL
$46.8B
| $712K | 0.24% |
7,788
-5,000
| -39% | -$457K |
|
24
ANI Pharmaceuticals
ANIP
$1.79B
| $665K | 0.22% |
19,000
| – | – |
|
25
Microsoft
MSFT
$2.94T
| $555K | 0.18% |
2,050
+507
| +33% | +$129K |
|
Similar funds
PC
AWA
FUBT
AC
EWM
ICP
ACM
GE
Defender Capital's Q2 2021 Portfolio in Review
As of Q2 2021, Defender Capital held 43 positions worth $301M, up 7.4% from $280M the previous quarter. Its ten largest holdings account for 88% of the portfolio.
Defender Capital withdrew a net $10.4M in Q2 2021, closing 3 positions and reducing 11 holdings. Its most notable exit was Palatin Technologies, an estimated $2.32M position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 40% of assets, up from 36% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Defender Capital opened a new position in Intel worth $1.22M.
- Defender Capital's largest Q2 2021 buy was Intel: 20,000 shares worth $1.22M.
- Defender Capital added most to Fortive in Q2 2021, an estimated $6.96M increase.
- Defender Capital's biggest Q2 2021 reduction was STAAR Surgical, cutting an estimated $8.51M.
- Defender Capital fully exited Palatin Technologies in Q2 2021, selling an estimated $2.32M.
- Defender Capital's ten largest holdings make up 88% of its $301M portfolio in Q2 2021.
- Defender Capital opened 5 new positions and closed 3 in Q2 2021.
- Defender Capital's portfolio value rose 7.4% quarter-over-quarter to $301M.
Based on Defender Capital's 13F filing for Q2 2021, filed 29 Jul 2021.